nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A deeper dive into the REPRIEVE trial and the potential role of inflammation in residual risk
|
Kalra, Dinesh K. |
|
|
17 |
5 |
p. 563-566 |
artikel |
2 |
Admission LDL-cholesterol, statin pretreatment and early outcomes in acute ischemic stroke
|
Kim, Joon-Tae |
|
|
17 |
5 |
p. 612-621 |
artikel |
3 |
Advances in understanding palmitic acid metabolism and health risks
|
Guyton, John R. |
|
|
17 |
5 |
p. 571-572 |
artikel |
4 |
Age-based disparities in statin use for primary prevention in US adults: National Health and Nutrition Examination Surveys 2013–2020
|
Zheutlin, Alexander R. |
|
|
17 |
5 |
p. 688-693 |
artikel |
5 |
Bilateral primary orbital xanthogranulomas: A case report and comparison of xanthomatous conditions
|
Eppley, Sarah E. |
|
|
17 |
5 |
p. 587-591 |
artikel |
6 |
Cholesterol screening and intervention in youth - It's time to move on
|
Liebeskind, Ann |
|
|
17 |
5 |
p. 573-576 |
artikel |
7 |
Clinical trials to improve outcomes in patients with elevated Lp(a) undergoing PCI: The time has arrived
|
Tsimikas, Sotirios |
|
|
17 |
5 |
p. 567-570 |
artikel |
8 |
Composition and distribution of lipoproteins after evolocumab in familial dysbetalipoproteinemia: A randomized controlled trial
|
Heidemann, Britt E. |
|
|
17 |
5 |
p. 666-676 |
artikel |
9 |
Diet-derived and diet-related endogenously produced palmitic acid: Effects on metabolic regulation and cardiovascular disease risk
|
Annevelink, Carmen E. |
|
|
17 |
5 |
p. 577-586 |
artikel |
10 |
Editorial Board
|
|
|
|
17 |
5 |
p. i-iii |
artikel |
11 |
From the Editors: More Hot Topics in Clinical Lipidology
|
Maki, Kevin C. |
|
|
17 |
5 |
p. 562 |
artikel |
12 |
Impact of providing genetics-based future cardiovascular risk on LDL-C in patients with familial hypercholesterolemia
|
Nomura, Akihiro |
|
|
17 |
5 |
p. 622-632 |
artikel |
13 |
Improved arterial inflammation with high dose omega-3 fatty acids in patients with elevated lipoprotein(a): Selective effect of eicosapentaenoic acid?
|
Ward, Natalie C. |
|
|
17 |
5 |
p. 694-699 |
artikel |
14 |
Integrated omics approach for the identification of HDL structure-function relationships in PCSK9-related familial hypercholesterolemia
|
Darabi, Maryam |
|
|
17 |
5 |
p. 643-658 |
artikel |
15 |
News from NLA
|
|
|
|
17 |
5 |
p. 561 |
artikel |
16 |
NLA/ASPC response to the USPSTF recommendation statement on screening lipid panel in children and adolescents
|
Goldberg, Anne Carol |
|
|
17 |
5 |
p. 559-560 |
artikel |
17 |
Plasma lipoprotein subclass variation in middle-aged and older adults: Sex-stratified distributions and associations with health status and cardiometabolic risk factors
|
Masuda, Reika |
|
|
17 |
5 |
p. 677-687 |
artikel |
18 |
Possible explanations for the common clinical familial hypercholesterolemia phenotypes in the Faroe Islands
|
Borg, Sanna á |
|
|
17 |
5 |
p. 633-642 |
artikel |
19 |
Table of Contents
|
|
|
|
17 |
5 |
p. iv-v |
artikel |
20 |
The efficacy of intensive lipid-lowering therapies on the reduction of LDLc and of major cardiovascular events
|
Cordero, Alberto |
|
|
17 |
5 |
p. 602-611 |
artikel |
21 |
Translating Evidence-based Approaches into optimal Care for individuals at High-risk of ASCVD: Pilot testing of case-based e-learning modules and design of the TEACH-ASCVD study
|
Clegg, Katarina |
|
|
17 |
5 |
p. 592-601 |
artikel |
22 |
Treatment of cerebrotendinous xanthomatosis in pregnancy: Patient and physician perspectives
|
Duell, P. Barton |
|
|
17 |
5 |
p. 700-703 |
artikel |
23 |
Variability of longitudinal triglyceride phenotype in patients heterozygous for pathogenic APOA5 variants
|
Perera, Shehan D. |
|
|
17 |
5 |
p. 659-665 |
artikel |